Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Byungwon Kim"'
Publikováno v:
International Neurourology Journal, Vol 26, Iss 3, Pp 248-257 (2022)
Purpose This study investigated functional outcomes in lower urinary tract symptoms (LUTS), the incidence of incidental prostate cancer (PCa), and changes in prostate-specific antigen (PSA) levels after holmium laser enucleation of the prostate (HoLE
Externí odkaz:
https://doaj.org/article/c44d8ee7f12f47f78dd6ea077720d848
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246921 (2021)
This work is motivated by the recent worldwide pandemic of the novel coronavirus disease (COVID-19). When an epidemiological disease is prevalent, estimating the case fatality rate, the proportion of deaths out of the total cases, accurately and quic
Externí odkaz:
https://doaj.org/article/5fc60a129a12474bb8ad1b663549a3e9
Autor:
Jeseok Lee, Byungwon Kim
Publikováno v:
Communications for Statistical Applications & Methods; May2024, Vol. 31 Issue 3, p349-363, 15p
Autor:
Byungwon Kim
Publikováno v:
Journal of the Korean Data And Information Science Society. 33:951-962
Publikováno v:
Journal of the Korean Data And Information Science Society. 33:927-936
Publikováno v:
Statistics in Medicine. 41:1728-1732
Autor:
Seok Kim, Ji-In Bang, Dachung Boo, Borham Kim, In Young Choi, SooJeong Ko, Ie Ryung Yoo, Kwangsoo Kim, Junmo Kim, YoungHwan Joo, Hyun Gee Ryoo, Jin Chul Paeng, Jung Mi Park, Woncheol Jang, Byungwon Kim, Yangha Chung, Dongyoon Yang, Sooyoung Yoo, Ho-Young Lee
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:3547-3556
Risk of second primary malignancy (SPM) after radioiodine (RAI) therapy has been continuously debated. The aim of this study is to identify the risk of SPM in thyroid cancer (TC) patients with RAI compared with TC patients without RAI from matched co
Publikováno v:
The Annals of Applied Statistics. 15
Objectives To understand the natural history of patients with prostate specific antigen (PSA) elevation receiving Holmium Laser Enucleation of the Prostate (HoLEP) for benign prostatic hyperplasia (BPH), and to understand clinical factors correlated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4483efe4313199b469478d538169d402
https://doi.org/10.21203/rs.3.rs-820767/v1
https://doi.org/10.21203/rs.3.rs-820767/v1
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246921 (2021)
PLoS ONE
PLoS ONE
This work is motivated by the recent worldwide pandemic of the novel coronavirus disease (COVID-19). When an epidemiological disease is prevalent, estimating the case fatality rate, the proportion of deaths out of the total cases, accurately and quic